Status:
RECRUITING
Personalized iTBS in Real-World Clinical Settings for Schizophrenia
Lead Sponsor:
Anhui Medical University
Conditions:
Schizophrenia
Transcranial Magnetic Stimulation
Eligibility:
All Genders
18-60 years
Phase:
NA
Brief Summary
This study is designed to determine whether neuronavigation-guided, personalized Intermittent Theta-Burst Stimulation (iTBS) can produce clinically benefits for patients with schizophrenia when delive...
Detailed Description
Effective intervention is critical for reducing relapse risk, improving long-term prognosis, and lowering healthcare costs for schizophrenia.The present study therefore aims to assess whether neuronav...
Eligibility Criteria
Inclusion
- Aged 18-60 years, any gender
- Meets DSM-5 criteria for schizophrenia
- Antipsychotic medication change (initiation, dose adjustment, or switch) occurred within the past 3 days
- Capable of understanding the study and providing written informed consent Able to comply with study procedures and complete assessments
Exclusion
- Active suicidal ideation or behavior
- Major neurological disorders (e.g., epilepsy, organic brain lesions, severe head trauma)
- Contraindications to MRI or TMS (e.g., metal implants, pacemakers)
- Pregnancy or lactation
- Receipt of TMS or ECT within the past 6 months
- Judged by investigators to be unsuitable for participation
Key Trial Info
Start Date :
October 20 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 20 2026
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT07176468
Start Date
October 20 2025
End Date
September 20 2026
Last Update
December 30 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Anhui Medical University
Hefei, Anhui, China, 230000
2
Anhui Medical University
Hefei, Anhui, China, 230032